Study results show that treatment with Seretide/Advair (salmeterol/fluticasone propionate ) slows the progression of Chronic Obstructive Pulmonary Disease (COPD) by lowering a patient’s rate of lung function decline compared with those receiving placebo.
Filed under: Nuclear Receptor | Tagged: Advair, agonist, Beta 2 Adrenoceptor, fluticasone, GKS, salmeterol
Name (required)
E-mail (will not be published) (required)
Website
Notify me of follow-up comments via email.
